Literature DB >> 11392596

Rupture of an unscarred uterus with misoprostol induction: case report and review of the literature.

A Y Khabbaz1, I M Usta, M I El-Hajj, A Abu-Musa, M Seoud, A H Nassar.   

Abstract

Uterine rupture is a serious and often tragic complication that is life threatening to both mother and child. It occurs at a frequency of around 1% in patients with a previously scarred uterus. Rupture of an unscarred uterus is an unexpected and devastating complication of pregnancy. With the increased use of misoprostol as a labor-inducing agent, cases of rupture of an unscarred uterus following its use have been published in the literature. We report a case of uterine rupture in a multigravid woman with an intrauterine fetal death at 29 weeks' gestation whose labor was induced with misoprostol. A review of all cases of uterine rupture with misoprostol induction is also included. Excessive doses of misoprostol should be used with extreme caution in multiparous women and in patients with a previously scarred uterus even in the context of intrauterine fetal death or termination of pregnancy.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11392596     DOI: 10.1080/714904310

Source DB:  PubMed          Journal:  J Matern Fetal Med        ISSN: 1057-0802


  3 in total

1.  The effects of prostaglandin E1 and prostaglandin E2 on in vitro myometrial contractility and uterine structure.

Authors:  Giuseppe Chiossi; Maged M Costantine; Egle Bytautiene; Talar Kechichian; Gary D V Hankins; Elena Sbrana; George R Saade; Monica Longo
Journal:  Am J Perinatol       Date:  2012-05-25       Impact factor: 1.862

Review 2.  A benefit-risk assessment of misoprostol for cervical ripening and labour induction.

Authors:  Deborah A Wing
Journal:  Drug Saf       Date:  2002       Impact factor: 5.606

3.  Ruptured uterus: Frequency, risk factors and feto-maternal outcome: Current scenario in a low-resource setup.

Authors:  Saida Abrar; Tahira Abrar; Ehsan Sayyed; Sidra Ali Naqvi
Journal:  PLoS One       Date:  2022-04-08       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.